Tasigna (nilotinib) Capsules Initial U.S. Approval: 2007

Categories: , .

Tasigna (nilotinib) Capsules Initial U.S. Approval: 2007

INDICATIONS AND USAGE
Tasigna is a kinase inhibitor indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant to or intolerant to prior therapy that included imatinib.
DOSAGE FORMS & STRENGTHS
200 mg hard capsules
Manufactured By: Novartis Pharmaceuticals Corporation
Prescribing Information URL: Click Here

Access to Tasigna ® (nilotinib) Capsules: Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Nilotinib, sold under the brand name Tasigna, is a medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib.
Nilotinib was approved for medical use in the United States in 2007. It is on the World Health Organization's List of Essential Medicines.
Nilotinib is used to treat Philadelphia chromosome (Ph+)-positive chronic myelogenous leukaemia.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.